Immunology

'Double agent' cells survival factor revealed

A group of `double agent' cells, which both protect us from some infections while also contributing to tissue damage in various inflammatory conditions, could be manipulated to offer a new approach to treating conditions ...

Inflammatory disorders

Inflammatory bowel disease: Incidence and treatment

Inflammatory bowel disease (IBD), with its two main disease entities Crohn's disease and ulcerative colitis, is a chronic and relapsing inflammation of the gastrointestinal tract. The highest prevalence of IBD is found in ...

Inflammatory disorders

Two new studies evaluate agents for treating ulcerative colitis

In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures. ...

page 1 from 3